Clinical trial
PROMISE-BIF ：A Prospective, Multicenter, Randomized Controlled Trial to Compare the Efficacy and Safety of Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter for the Treatment of De Novo Coronary Bifurcated Lesions
NCT04918615 is registered in ClinicalTrials.gov with Shanghai MicroPort Medical (Group) Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PROMISE-BIF ：A Prospective, Multicenter, Randomized Controlled Trial to Compare the Efficacy and Safety of Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter for the Treatment of De Novo Coronary Bifurcated Lesions
- Lead sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 28, 2021
- Completion date
- December 31, 2024
- Enrollment
- 236 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.